All posts tagged drug development

  • Collaboration Between CU Cancer Center and NantBioScience Targets Ral Protein

    Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs that target Ral protein activation, implicated in nearly a third of all cancers.

Cancer Stem Cells